193 related articles for article (PubMed ID: 31728746)
21. Erratum to: Kinetic Characterization of Tyrosinase-catalyzed Oxidation of Four Polyphenols.
Liu WY; Zou CM; Hu JH; Xu ZJ; Si LQ; Liu JJ; Huang JG
Curr Med Sci; 2020 Jun; 40(3):594. PubMed ID: 32681265
[TBL] [Abstract][Full Text] [Related]
22. Correction to: Alternative NADH dehydrogenase extends lifespan and increases resistance to xenobiotics in Drosophila.
Gospodaryov DV; Strilbytska OM; Semaniuk UV; Perkhulyn NV; Rovenko BM; Yurkevych IS; Barata AG; Dick TP; Lushchak OV; Jacobs HT
Biogerontology; 2020 Apr; 21(2):173-174. PubMed ID: 31989363
[TBL] [Abstract][Full Text] [Related]
23. Correction to: Safety of orogastric tubes in foregut and bariatric surgery.
Nandra K; Ing R
Surg Endosc; 2019 Aug; 33(8):2719. PubMed ID: 30980135
[TBL] [Abstract][Full Text] [Related]
24. Correction to: How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.
Hoch E; Niemann D; von Keller R; Schneider M; Friemel CM; Preuss UW; Hasan A; Pogarell O
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):995. PubMed ID: 30953129
[TBL] [Abstract][Full Text] [Related]
25. Erratum to: Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics.
Chao XL; Jiang SZ; Xiong JW; Zhan JQ; Wei B; Chen CN; Yang YJ
Curr Med Sci; 2020 Oct; 40(5):997. PubMed ID: 33123913
[TBL] [Abstract][Full Text] [Related]
26. Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy.
Wardell SE; Yllanes AP; Chao CA; Bae Y; Andreano KJ; Desautels TK; Heetderks KA; Blitzer JT; Norris JD; McDonnell DP
Breast Cancer Res Treat; 2020 Feb; 179(3):769. PubMed ID: 31734822
[TBL] [Abstract][Full Text] [Related]
27. Correction to: GP2015: An Etanercept Biosimilar.
Deeks ED
BioDrugs; 2018 Oct; 32(5):525. PubMed ID: 30069733
[TBL] [Abstract][Full Text] [Related]
28. Erratum to: Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer's Disease.
Wei H; Zhang HL; Xie JZ; Meng DL; Wang XC; Ke D; Zeng J; Liu R
Curr Med Sci; 2020 Apr; 40(2):389. PubMed ID: 32337701
[TBL] [Abstract][Full Text] [Related]
29. Erratum to: Genistein-induced Anticancer Effects on Acute Leukemia Cells Involve the Regulation of Wnt Signaling Pathway Through H4K20me1 Rather Than DNA Demethylation.
Zhou HR; Shen JZ; Fu HY; Zhang F
Curr Med Sci; 2021 Dec; 41(6):1257. PubMed ID: 35435596
[TBL] [Abstract][Full Text] [Related]
30. Correction to: Ubrogepant: First Approval.
Scott LJ
Drugs; 2020 Apr; 80(5):523. PubMed ID: 32166599
[TBL] [Abstract][Full Text] [Related]
31. Correction to: Migalastat: A Review in Fabry Disease.
McCafferty EH; Scott LJ
Drugs; 2019 Aug; 79(12):1363. PubMed ID: 31292908
[TBL] [Abstract][Full Text] [Related]
32. Correction to: Nonacog Beta Pegol: A Review in Haemophilia B.
Syed YY
Drugs; 2018 Jul; 78(11):1169. PubMed ID: 30003467
[TBL] [Abstract][Full Text] [Related]
33. Correction to: Antiinflammatory constituents of Atractylodes chinensis rhizome improve glomerular lesions in immunoglobulin A nephropathy model mice.
Ishii T; Okuyama T; Noguchi N; Nishidono Y; Okumura T; Kaibori M; Tanaka K; Terabayashi S; Ikeya Y; Nishizawa M
J Nat Med; 2020 Jun; 74(3):616. PubMed ID: 32274684
[TBL] [Abstract][Full Text] [Related]
34. Correction to: Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.
Deeks ED
Drugs; 2019 Apr; 79(6):687. PubMed ID: 30903610
[TBL] [Abstract][Full Text] [Related]
35. Correction to: Lonoctocog Alfa: A Review in Haemophilia A.
Al-Salama ZT; Scott LJ
Drugs; 2018 Mar; 78(4):521. PubMed ID: 29500556
[TBL] [Abstract][Full Text] [Related]
36. Correction to: Tocilizumab: A Review in Rheumatoid Arthritis.
Scott LJ
Drugs; 2018 Feb; 78(2):285. PubMed ID: 29260457
[TBL] [Abstract][Full Text] [Related]
37. Correction to: Is the new ASNM intraoperative neuromonitoring supervision "guideline" a trustworthy guideline? A commentary.
Skinner SA; Aydinlar EI; Borges LF; Carter BS; Currier BL; Deletis V; Dong C; Dormans JP; Drost G; Fernandez-Conejero I; Hoffman EM; Holdefer RN; Kimaid PAT; Koht A; Kothbauer KF; MacDonald DB; McAuliffe JJ; Morledge DE; Morris SH; Norton J; Novak K; Park KS; Perra JH; Prell J; Rippe DM; Sala F; Schwartz DM; Segura MJ; Seidel K; Seubert C; Simon MV; Soto F; Strommen JA; Szelenyi A; Tello A; Ulkatan S; Urriza J; Wilkinson M
J Clin Monit Comput; 2019 Apr; 33(2):191-192. PubMed ID: 30778916
[TBL] [Abstract][Full Text] [Related]
38. Correction to: Urinary metabolic profiling of asymptomatic acute intermittent porphyria using a rule-mining-based algorithm.
Luck M; Schmitt C; Talbi N; Gouya L; Caradeuc C; Puy H; Bertho G; Pallet N
Metabolomics; 2018 Jan; 14(3):21. PubMed ID: 30830333
[TBL] [Abstract][Full Text] [Related]
39. Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features.
Lyseng-Williamson KA
Clin Drug Investig; 2019 Oct; 39(10):1019. PubMed ID: 31512163
[TBL] [Abstract][Full Text] [Related]
40. Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
Nitz U; Gluz O; Christgen M; Kates RE; Clemens M; Malter W; Nuding B; Aktas B; Kuemmel S; Reimer T; Stefek A; Lorenz-Salehi F; Krabisch P; Just M; Augustin D; Liedtke C; Chao C; Shak S; Wuerstlein R; Kreipe HH; Harbeck N
Breast Cancer Res Treat; 2019 May; 175(1):265-266. PubMed ID: 30632020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
